Experiences with
Fludarabine, cyclophosphamide and rituximab (FCR)866 public posts
Want to take advantage of all our features? Just log in!
or
Progression Free Survival (PFS) post Discontinuation of Ibrutinib in E1912 Trial
superior to FCR in IGHV [i]unmutated[/i] patients but [i]not in IGHV mutated[/i] patients.
Novel Combos Are Shaking Up the CLL Landscape but FCR still has its place
In analyzing which patients derived the most benefit from the former standard of care, Jain said data from prior studies showed frontline FCR therapy resulted in favorable long-term progression-free survival (PFS) in patients with IGHV mutations who had achieved undetectable minimal residual disease